Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Biphenotypic, Acute × Dasatinib × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Burkitt Lymphoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Brain Neoplasms 1 Blast Crisis 1

Interventions

Cytarabine 7 Cyclophosphamide 7 venetoclax 5 fludarabine 5 Mycophenolic Acid 5 Methotrexate 5 Granulocyte Colony-Stimulating Factor 5 Filgrastim 5 Whole-Body Irradiation 4 Vincristine 4 Stem Cell Transplantation 4 Specimen Handling 4 Hydrocortisone 4 Dexamethasone 4 Azacitidine 4 revumenib 3 fludarabine phosphate 3 dexamethasone acetate 3 dexamethasone 21-phosphate 3 calaspargase pegol 3 Mesna 3 Leucovorin 3 Doxorubicin 3 Daunorubicin 3 Calcium Dobesilate 3 Bone Marrow Transplantation 3 merphos 2 exifone 2 azathiopurine 2 auricularum 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡